Free Webinar Aims to Enhance Understanding of ADC Manufacturing

On Thursday, September 24, 2026, from 12 pm Eastern Daylight Time (6 pm Central European Summer Time / EU-Central), Xtalks will host a free webinar aimed at enhancing understanding of antibody-drug conjugate (ADC) manufacturing. The event will focus on the critical role of consistent antibody quality in supporting efficient ADC production.

Featured speaker Dr. Dave Briggs, Principal Scientist at Avid Bioservices, will guide attendees through key development considerations for ADCs, including antigen specificity, binding strength, structural stability, and conjugation readiness. The webinar will explore how maintaining consistent quality attributes throughout development and manufacturing is essential, particularly as ADCs approach the complex task of conjugation with potent payloads.

Attendees will gain insights into how upstream cell line development and production processes influence antibody output. Dr. Briggs will also discuss downstream purification techniques that help isolate and purify the antibody, removing impurities before the molecule advances to payload attachment.

Scaling up ADC programs from early development to clinical and commercial manufacturing introduces new challenges. The webinar will address how stable antibody quality during manufacturing scale-up can support efficient conjugation, reduce variability, and contribute to more predictable final ADC performance. A case study will illustrate the impact of variability in antibody glycosylation patterns on conjugation efficiency and how optimizing upstream processes can improve consistency in antibody quality and overall manufacturing performance.

Experienced Contract Development and Manufacturing Organization (CDMO) support will be highlighted as a crucial factor in establishing reliable antibody production processes, addressing quality variability, and progressing toward downstream conjugation and commercial readiness. Attendees will leave with a clearer understanding of how manufacturing and scale-up decisions impact ADC development and support targeted oncology programs.

To register for this webinar and learn how ADC manufacturing strategies can improve antibody consistency, support efficient conjugation, and reduce scale-up risk, visit the event registration page.

The webinar is part of Xtalks’ ongoing mission to empower professionals in the life sciences sector with trusted knowledge and collaborative insights. Xtalks, The Life Science Community™, powered by Honeycomb Worldwide Inc., delivers news, feature articles, webinars, podcasts, videos, expert interviews, and more to support informed decision-making in a rapidly evolving industry.

Thousands of professionals rely on Xtalks annually for timely intelligence, peer perspectives, and industry thought leadership. Join the community to stay informed, connected, and prepared for future challenges in the life sciences.